RxDoctor Payments Data

James Martin, APRN

Nurse Practitioner · Tampa, FLNPI 1801484548

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,268 of the $1,455 with a category attached, or 87.1%. It is spread thinly across 18 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $847, more than ten times the $42 reported in 2021.

$1,455in general payments, 2019–2025

Across 58 payments — averaging $25.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$230
  • Regeneron Healthcare Solutions, Inc.$202
  • Sanofi$183
  • AbbVie$153
  • Novartis$130
  • Pfizer$113
  • plus $444 from 12 others

What the payments were for

  • Food & beverage$1,26887%
  • Education$18713%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,455 in reported general payments places this provider in the 75th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida →

Medicare billing

Part B allowed, 2024
$4,267
Medicare patients
29
Services billed
71

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab16$58,428
Clobetasol Propionate251$13,829
Ketoconazole258$3,291
Tacrolimus18$2,169
Triamcinolone Acetonide144$1,488
Azelaic Acid11$1,476
Ammonium Lactate98$1,473
Hydrocortisone93$1,153
Ciclopirox49$1,120
Tretinoin12$1,118
Mometasone Furoate47$939
Clindamycin Phosphate32$926
Fluocinolone AcetonideFluocinolone/Shower Cap14$837
Doxycycline Hyclate44$593
Betamethasone Valerate18$528

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Tampa

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →